Animal and translational models for CNS drug discovery

The use of appropriate models can minimize the number of drug candidates thatlater fail in human trials by accurately predicting the efficacy and the toxicity of each compound. This can be improved with more informed selection of the appropriate models. This three-volume set provides specific guidelines to selecting the appropriate non-human models for trials in the drug discovery and development process. It offers a unique perspectice from the three principle players in the drug discovery process: Industry, Academic, Government, and Clinical. Each volume is devoted to specific disorders in three scientific fields:Psychiatric, Neurological, and Reward Deficit.* Details for each disorder on how to analyze and determine what the results mean to the overall drug discovery/development process* Real-life trial case studies demonstrate how to move to human clinical trial phase* All volumes also sold individually

• ISBN: 978-0-12-373861-5
• Editorial: Academic Press
• Encuadernacion: Cartoné
• Páginas: 1376
• Fecha Publicación: 11/11/2008
• Nº Volúmenes: 3
• Idioma: Inglés